Harnessing frontier cancer targets through exceptional drug discovery that is inspired by nature’s lessons

REVOLUTION Medicines discovers and develops new drugs that harness the therapeutic potential of frontier oncology targets on behalf of cancer patients. The company’s innovative product engine draws inspiration from nature and evolution, which offer insights into cancer targets, disease mechanisms and therapeutic approaches. In 2018, REVOLUTION acquired Warp Drive Bio, Inc., a company focused on exploiting the molecules and mechanisms of nature to create transformative medicines.

Year Invested: 2015
Location: Redwood City, Calif.
Visit: www.revolutionmedicines.com

Recent News

January 3, 2019
REVOLUTION Medicines to Present at the J.P. Morgan Healthcare Conference on January 8, 2019

November 13, 2018
REVOLUTION Medicines Announces Presentations at Scientific Meetings in Third and Fourth Quarters of 2018

October 16, 2018
REVOLUTION Medicines Acquires Warp Drive Bio to Expand Drug Discovery Portfolio Focused on Frontier Oncology Targets

Read More News

Associated Team Members

Neil Exter

Alexis Borisy